EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches

Hourieh Kalhor, Mohammad Hossein Mokhtarian iD, Hamzeh Rahimi, Behzad Shahbazi, Reyhaneh Kalhor, Tahereh Komeili Movahed, Hoda Abolhasani

Iranian Journal of Pharmaceutical Research · 08.12.2024 · 23 (1)

DOI: 10.5812/ijpr-150879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 08.12.2024. Verfasst von Hourieh Kalhor und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 interacts with the angiotensin-converting enzyme 2 (ACE2) receptor in humans. To date, numerous SARS-CoV-2 variants, particularly those involving mutations in the RBD, have been identified. These variants exhibit differences in transmission, pathogenicity, diagnostics, and vaccine efficacy.

Objectives

Although therapeutic agents are currently available to inhibit SARS-CoV-2, most provide supportive and symptomatic relief. Moreover, different variants may exhibit resistance to these treatments. This study aimed to identify a potential compound with favorable antiviral effects against SARS-CoV-2 variants.

Methods

The study explored drug discovery through structure-based virtual screening of natural products (NPs) from the StreptomeDB database, targeting the ACE2-binding pocket of the SARS-CoV-2 RBD protein. The analysis included the wild-type protein (PDB ID: 6VW1) as well as the Alpha, Beta, Delta, Lambda, Omicron/BA.1, and Omicron/BA.2 variants.

Results

In silico screening identified ‘Stambomycin B’ as a potential compound with the highest binding affinity. Molecular dynamics simulations of the complexes, conducted over 100 ns, confirmed the prediction that ‘Stambomycin B’ could inhibit different SARS-CoV-2 variants effectively.

Conclusions

This study concludes that ‘Stambomycin B’, a macrolide compound produced by Streptomyces ambofaciens, may be a candidate NP for effectively combating all mutants that occur in the binding of SARS-CoV-2 RBD to ACE2, even those that may arise in the future.

Schlagwörter

Stichwörter der Autor:innen

ACE2Molecular DockingMolecular Dynamics SimulationSARS-CoV-2Stambomycin B

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Garmsar Branch, Islamic Azad University, Garmsar, Iran.
  • Department of Neurosurgery, City of Hope, California, USA.
  • School of Pharmacy, Semnan University of Medical Sciences, Semnan, Iran.
  • Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Department of Pharmacology, School of Medicine, Qom University of Medical Sciences, Qom, Iran.

ORCID-Profile: Mohammad Hossein Mokhtarian

Zitieren

APA

Kalhor, H., Mokhtarian, M. H., Rahimi, H., Shahbazi, B., Kalhor, R., Komeili Movahed, T., & Abolhasani, H. (2024). Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches. Iranian Journal of Pharmaceutical Research, 23(1). https://doi.org/10.5812/ijpr-150879

Vancouver

Kalhor H, Mokhtarian MH, Rahimi H, Shahbazi B, Kalhor R, Komeili Movahed T, et al. Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches. Iranian Journal of Pharmaceutical Research. 2024;23(1). doi:10.5812/ijpr-150879

BibTeX
@article{Kalhor2024,
  author = {Kalhor, Hourieh and Mokhtarian, Mohammad Hossein and Rahimi, Hamzeh and Shahbazi, Behzad and Kalhor, Reyhaneh and Komeili Movahed, Tahereh and Abolhasani, Hoda},
  title = {Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.5812/ijpr-150879}
}
Kostenlos starten →